Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Nicole Rethemeier's publication output changed over time?
ScholarIQpublication output · 2022–2026
Output grew100% over the shown period — from 1 works in 2022 to 2 in 2026.
1
1
1
2
2022202320252026
What are the most-cited papers on Nicole Rethemeier?
ScholarIQmost cited works
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Luís M. Ruilope, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Pantelis Sarafidis, Roland E. Schmieder, Amer Joseph, Nicole Rethemeier, Christina Nowack, George L. Bakris, on behalf of the FIDELIO-DKD Investigators
Hypertension. 2022100 CitationsOPEN ACCESS
Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review
Dustin J. Little, Samvel B. Gasparyan, Patrick Schloemer, Niels Jongs, Meike Brinker, Martin Karpefors, Christoph Tasto, Nicole Rethemeier, Lars Frison, Richard Nkulikiyinka, Jérôme Rossert, Hiddo J.L. Heerspink
Journal of the American Society of Nephrology. 202332 CitationsOPEN ACCESS
Finerenone in Persons with Chronic Kidney Disease without Diabetes
Hiddo J.L. Heerspink, Brendon L. Neuen, Rajiv Agarwal, D Cherney, C S P Lam, K R Tuttle, Christoph Wanner, Pantelis Sarafidis, Niels Jongs, J David Smeijer, Meike Brinker, Nicole Rethemeier, Patrick Schloemer, Paula Vesterinen, David Goldsbury, Sara Dizayee, Jon W. Mares, V Perkovic
New England Journal of Medicine. 20269 Citations
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases
Brendon L. Neuen, V Perkovic, Rajiv Agarwal, D Cherney, C S P Lam, Christoph Wanner, K R Tuttle, Pantelis Sarafidis, Jonathan Barratt, Anna Burgner, Xiangmei Chen, Alfredo Chew‐Wong, Vladimir A. Dobronravov, Jürgen Floege, Kieran McCafferty, Masaomi Nangaku, David Packham, Evangelos Papachristou, Pablo E. Pérgola, Marijn M. Speeckaert, Arunkumar Subbiah, Sydney CW Tang, Shuifu Tang, See Cheng Yeo, Niels Jongs, J David Smeijer, Mario Berger, Meike Brinker, Rania Dayoub, Jay Elliott, Na Li, Katharina Mueller, Nicole Rethemeier, Marina Yael Finkelsztein, Hiddo J. L. Heerspink, FIND-CKD Investigators, Glenn M. Chertow, Tim Friede, Adeera Levin, Johannes F.E. Mann, Rafaël Maldonado, Paola Aguerre, Paula Arenas, M. Arriola, Claudia Emilce Baccaro, Maria Bevilacqua, Julio Bittar, Dafne Brodschi, Julia Cáceres, Gina Campestri, Maria Cecilia Cantero, Santiago Cardona, Florencia Casan, Evelin Cassini, Gustavo Catalano, Mariano Chahin, Natalia Cluigt, Ana Florencia Comes, Pamela Delgado, Maria Paula Dionisi, Silvina Dominguez, Rocio Fernandez, Elizabeth Gelersztein, Sandra Giacometti, Diego Andres Mohr Gosparini, Fernando Pedro Guerlloy, Fernando Halac, Miguel Hominal, Cecilia Igarzabal, Veronica Lacoste, Micaela Leis, Pablo Martinez, Virginia Rama, Lucia Rodriguez, Silvia Rodriguez, Luciana Rovegno, Benjamin Saenz, Maria Victoria Sobredo, Matias Suarez, Patricia Varela, Guido Villalobo, Sernia Virginia, Diego Waserman, Daniela Magali Zaccaro, Javier Zaidman, S Badve, Melissa Cheetham, Jenny Chen, Kathryn Ducharlet, Dov Degen, Yusuf Eqbal, Adam Flavell, Celine Foote, Nicholas Gray, Carmel Hawley, Peter Hollett, Jane Holt, Louis Huang, Nicole Isbel, Dev Jegatheesan
JAMA. 20265 CitationsOPEN ACCESS
Interpretational challenges of the Win Ratio in analyzing Hierarchical Composite Endpoints in Chronic Kidney Disease
Henrik F. Thomsen, Samvel B. Gasparyan, Julie F. Furberg, Christoph Tasto, Nicole Rethemeier, Patrick Schloemer, Tuo Wang, Niels Jongs, Du Yu, Tom Greene
arXiv (Cornell University). 20250 CitationsOPEN ACCESS
Related on ScholarIQ
Bayer (Germany)
Institution
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Paper
Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review
Paper
Finerenone in Persons with Chronic Kidney Disease without Diabetes
Paper
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases
Paper
Interpretational challenges of the Win Ratio in analyzing Hierarchical Composite Endpoints in Chronic Kidney Disease
Paper